InMode INMD 2025Q2 Earnings Preview Downside Risk Amid Revised Revenue Guidance
Generated by AI AgentAinvestweb
Monday, Jul 28, 2025 2:53 am ET1min read
INMD--
Aime Summary
Aime SummaryForward-Looking Analysis
InMode is set to report its Q2 2025 earnings on July 30, amidst revised full-year revenue guidance, down by $30 million. Analysts project a year-over-year increase in earnings driven by higher revenues. The current EPS estimate for the quarter stands at $0.41, reflecting growth from Q1’s EPS of $0.26. The trailing EPS is $2.33 with a P/E ratio of 6.31. InMode's earnings are expected to grow by 4% next year. Despite a consensus "Hold" rating from six analysts, the stock's average price target is set at $17.56, indicating a potential 20.85% price increase.
Historical Performance Review
In Q1 2025, InModeINMD-- reported revenues of $77.87 million and net income of $18.20 million, alongside an EPS of $0.26. The gross profit for the quarter was $60.91 million. This performance marked a decrease from the previous quarter but showed a modest year-over-year increase, as the EPS rose by 7.14%, despite a decline in net income compared to the same quarter last year.
Additional News
InMode recently announced preliminary financial expectations for Q2 2025, along with a revised revenue outlook for the year, reducing projections by $30 million. While the company has maintained profitability, reporting a net profit of $175.78 million over the past year, this adjustment reflects potential challenges in maintaining growth momentum. Despite this, InMode's return on equity remains strong at 25%, showcasing its efficiency in generating shareholder returns compared to the broader medical devices industry.
Summary & Outlook
InMode's financial health remains solid, with strong return metrics and profitability. However, reduced revenue guidance signals potential risks ahead. While analysts predict an increase in stock price and EPS growth, the overall outlook remains cautious. The company's ability to adapt to revised expectations will be crucial. As InMode navigates these challenges, the outlook can be described as neutral, balancing growth prospects against emerging risks. Focus will be on maintaining earnings growth and leveraging operational efficiencies to support future performance.
InMode is set to report its Q2 2025 earnings on July 30, amidst revised full-year revenue guidance, down by $30 million. Analysts project a year-over-year increase in earnings driven by higher revenues. The current EPS estimate for the quarter stands at $0.41, reflecting growth from Q1’s EPS of $0.26. The trailing EPS is $2.33 with a P/E ratio of 6.31. InMode's earnings are expected to grow by 4% next year. Despite a consensus "Hold" rating from six analysts, the stock's average price target is set at $17.56, indicating a potential 20.85% price increase.
Historical Performance Review
In Q1 2025, InModeINMD-- reported revenues of $77.87 million and net income of $18.20 million, alongside an EPS of $0.26. The gross profit for the quarter was $60.91 million. This performance marked a decrease from the previous quarter but showed a modest year-over-year increase, as the EPS rose by 7.14%, despite a decline in net income compared to the same quarter last year.
Additional News
InMode recently announced preliminary financial expectations for Q2 2025, along with a revised revenue outlook for the year, reducing projections by $30 million. While the company has maintained profitability, reporting a net profit of $175.78 million over the past year, this adjustment reflects potential challenges in maintaining growth momentum. Despite this, InMode's return on equity remains strong at 25%, showcasing its efficiency in generating shareholder returns compared to the broader medical devices industry.
Summary & Outlook
InMode's financial health remains solid, with strong return metrics and profitability. However, reduced revenue guidance signals potential risks ahead. While analysts predict an increase in stock price and EPS growth, the overall outlook remains cautious. The company's ability to adapt to revised expectations will be crucial. As InMode navigates these challenges, the outlook can be described as neutral, balancing growth prospects against emerging risks. Focus will be on maintaining earnings growth and leveraging operational efficiencies to support future performance.
This internal account is for our software. It'll answer users' questions about subscription products, aiming to boost adoption and retention.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet